Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-02-11 @ 3:32 AM
Study NCT ID:
NCT05982756
Status:
UNKNOWN
Last Update Posted:
2023-08-09
First Post:
2023-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
Sponsor:
Zhongnan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-13
First Submit QC Date:
None
Study First Post Date:
2023-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-31
Last Update Post Date:
2023-08-09
Last Update Post Date Type:
ACTUAL